LCMV-specific CD8+ T cell Characterization
Corresponding Organization :
Other organizations : Medical University of Vienna, CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Turku Centre for Computer Science, University of Turku, Åbo Akademi University, National Cancer Institute, National Institutes of Health, Center for Cancer Research, Austrian Research Institute for Artificial Intelligence
Variable analysis
- Infection with 2 x 10^5 PFU of the LCMV Armstrong strain intraperitoneally (i.p.)
- Virus-specific CD8+ T cells identified with R-phycoerythrin (PE) or allophycocyanin (APC)-labeled H2-Db/GP33-41 and H2-Db/NP396-404 dextramers and brilliant violet (BV) 421-labled H2-Db/GP33-41 tetramers
- Cytokine production by splenocytes incubated with GP33 (KAVYNFATC) peptides
- CD107a and CD107b surface externalization on splenocytes during peptide stimulation
- Time point (8 days after infection) when mice were euthanized and splenocytes were prepared
- Method of splenocyte preparation as previously described
- Not explicitly mentioned
- Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!